VIOLIN Logo
Virmugen Banner
Search: for Help
Virmugen Home
Introduction
Statistics
News and Updates
Virmugen Query
Virmugen Blast
Data Submission
Data Exchange
Data Download
Documentation
FAQs
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaccine Comparison

Influenza virus CTA1-3M2e-DD protein vaccine Influenza virus NS1 mutant vaccine
Vaccine Information Vaccine Information
  • Vaccine Ontology ID: VO_0002980
  • Type: Subunit vaccine
  • Status: Research
  • Antigen: Influenza A virus (A/Puerto Rico/8/34(H1N1)) matrix protein 2 (M2)
  • M2 from Influenza A virus (A/Puerto Rico/8/34(H1N1)) gene engineering:
    • Type: Recombinant protein preparation
    • Description: The fusion proteins were expressed in E. coli DH5 cells, transformed with the expression vectors for the CTA1-DD, CTA1-M2e-DD or the CTA1-3M2e-DD fusion proteins, and grown in 500 ml cultures over night in SYPPG medium with 100 μg/ml carbenicillin, at 37 °C. The cells were harvested by centrifugation and the fusion proteins, produced as inclusion bodies, were washed before extraction by treatment with 8 M urea. After refolding the proteins by slowly diluting them 35–40x in Tris–HCl pH 7.4 at +4 °C, the fusion proteins were purified in two steps, by ion exchange and size exclusion chromatography. After concentration and sterile filtration the purified fusion proteins were stored in PBS at −80 °C until use (Eliasson et al., 2008).
    • Detailed Gene Information: Click Here.
  • Adjuvant: cholera toxin A1-subunit-ProteinA D-fragment fusion protein
  • Immunization Route: Intranasal
  • Vaccine Ontology ID: VO_0002981
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse, pig, horse, macaque
  • NS1 from Influenza virus gene engineering:
  • Immunization Route: intranasal immunization
References References
Eliasson et al., 2008: Eliasson DG, El Bakkouri K, Schön K, Ramne A, Festjens E, Löwenadler B, Fiers W, Saelens X, Lycke N. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine. 2008; 26(9); 1243-1252. [PubMed: 18243429].
Richt and García-Sastre, 2009: Richt JA, García-Sastre A. Attenuated influenza virus vaccines with modified NS1 proteins. Current topics in microbiology and immunology. 2009; 333; 177-195. [PubMed: 19768406].